https://www.patlynk.com/trial/NCT00004831
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria | PatLynk
PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, crossover study. Patients are randomly assigned to 1 of 2 groups to receive cysteine h
cysteine hydrochlorideerythropoietic protoporphyriastudy
https://www.patlynk.com/fr/trial/NCT00004831
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria | PatLynk
PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, crossover study. Patients are randomly assigned to 1 of 2 groups to receive cysteine h
cysteine hydrochlorideerythropoietic protoporphyriastudy